Coronary Artery Disease Clinical Trial
— COLOROfficial title:
Chemometric Observation of Lipid Core Plaques of Interest in Native Coronary Arteries Registry
Verified date | June 2017 |
Source | InfraReDx |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
In April 2008, a coronary catheter based imaging system, LipiScan, was cleared by the FDA for use in detecting lipid core containing containing plaques of interest (LCP). These plaques are rich in cholesterol. The way that cholesterol and other lipids deposit with the coronary artery is unique to each patient. This study is an organized attempt to observe the LCP and the variety of ways that it presents in patients as detected by this recently approved device. This information will be used for physician training and to observe the behavior of the LCP in response to no therapy and currently approved therapies. The purpose of this project is further medical knowledge of the LCP and its treatment.
Status | Completed |
Enrollment | 2067 |
Est. completion date | April 2017 |
Est. primary completion date | February 2016 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: - Subject is at least 18 years of age. - Subject is scheduled for elective coronary catheterization. - LipiScan CIS, LipiScan IVUS Imaging System, or TVC Imaging System use is not contra-indicated. - At least one chemogram from a native coronary artery is available for submission to the registry. - Able to read, understand and sign the informed consent. Exclusion Criteria: - Subject is pregnant or nursing. - Subject life expectancy is less than 2 years at time of index catheterization. - All submitted chemograms are obtained with the LipiScan, LipiScan IVUS, or TVC(R) Imaging Catheter positioned within a coronary artery bypass graft. - Unable to give informed consent |
Country | Name | City | State |
---|---|---|---|
United States | Piedmont Hospital | Atlanta | Georgia |
United States | Beth Israel Deaconess Medical Center | Boston | Massachusetts |
United States | Massachusetts General Hospital | Boston | Massachusetts |
United States | Lahey Clinic | Burlington | Massachusetts |
United States | Medical University of South Carolina Hospital | Charleston | South Carolina |
United States | Veterans Affairs, North Texas Health Care Systems | Dallas | Texas |
United States | University of Florida, Gainesville | Gainesville | Florida |
United States | Mercy Gilbert Medical Center | Gilbert | Arizona |
United States | Pinnacle Heart & Vascular Institute | Harrisburg | Pennsylvania |
United States | University of California, Los Angeles Medical Center | Los Angeles | California |
United States | Columbia Universtiy Medical Center | New York | New York |
United States | Mount Sinai School of Medicine | New York | New York |
United States | University of California Irvine Medical Center | Orange | California |
United States | Mayo Clinic | Rochester | Minnesota |
United States | Crittenton Shelton Heart Center: | Rochester Hills | Michigan |
United States | William Beaumont Hospital | Royal Oak | Michigan |
United States | Saint Louis University Hospital | Saint Louis | Missouri |
United States | San Francisco Veterans Affairs Medical Center | San Francisco | California |
United States | Scottsdale Healthcare | Scottsdale | Arizona |
United States | Swedish Medical Center | Seattle | Washington |
United States | Washington Adventist Hospital | Takoma Park | Maryland |
United States | Pepin Heart Hospital | Tampa | Florida |
Lead Sponsor | Collaborator |
---|---|
InfraReDx |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Identify associations of LCP with angiographic or symptomatic presentation of coronary artery disease in a catheterization laboratory population | after completion of the study - during data analysis | ||
Secondary | Identification of associations that LCP or the Lipid Core Burden Index (LCBI) may have with atherosclerosis appearance, progression, regression, and/or cardiac event | Upto 2 years post procedure(baseline) |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT06030596 -
SPECT Myocardial Blood Flow Quantification for Diagnosis of Ischemic Heart Disease Determined by Fraction Flow Reserve
|
||
Completed |
NCT04080700 -
Korean Prospective Registry for Evaluating the Safety and Efficacy of Distal Radial Approach (KODRA)
|
||
Recruiting |
NCT03810599 -
Patient-reported Outcomes in the Bergen Early Cardiac Rehabilitation Study
|
N/A | |
Recruiting |
NCT06002932 -
Comparison of PROVISIONal 1-stent Strategy With DEB Versus Planned 2-stent Strategy in Coronary Bifurcation Lesions.
|
N/A | |
Not yet recruiting |
NCT06032572 -
Evaluation of the Safety and Effectiveness of the VRS100 System in PCI (ESSENCE)
|
N/A | |
Recruiting |
NCT04242134 -
Drug-coating Balloon Angioplasties for True Coronary Bifurcation Lesions
|
N/A | |
Recruiting |
NCT05308719 -
Nasal Oxygen Therapy After Cardiac Surgery
|
N/A | |
Completed |
NCT04556994 -
Phase 1 Cardiac Rehabilitation With and Without Lower Limb Paddling Effects in Post CABG Patients.
|
N/A | |
Recruiting |
NCT05846893 -
Drug-Coated Balloon vs. Drug-Eluting Stent for Clinical Outcomes in Patients With Large Coronary Artery Disease
|
N/A | |
Recruiting |
NCT06027788 -
CTSN Embolic Protection Trial
|
N/A | |
Recruiting |
NCT05023629 -
STunning After Balloon Occlusion
|
N/A | |
Completed |
NCT04941560 -
Assessing the Association Between Multi-dimension Facial Characteristics and Coronary Artery Diseases
|
||
Completed |
NCT04006288 -
Switching From DAPT to Dual Pathway Inhibition With Low-dose Rivaroxaban in Adjunct to Aspirin in Patients With Coronary Artery Disease
|
Phase 4 | |
Completed |
NCT01860274 -
Meshed Vein Graft Patency Trial - VEST
|
N/A | |
Recruiting |
NCT06174090 -
The Effect of Video Education on Pain, Anxiety and Knowledge Levels of Coronary Bypass Graft Surgery Patients
|
N/A | |
Terminated |
NCT03959072 -
Cardiac Cath Lab Staff Radiation Exposure
|
||
Completed |
NCT03968809 -
Role of Cardioflux in Predicting Coronary Artery Disease (CAD) Outcomes
|
||
Recruiting |
NCT04566497 -
Assessment of Adverse Outcome in Asymptomatic Patients With Prior Coronary Revascularization Who Have a Systematic Stress Testing Strategy Or a Non-testing Strategy During Long-term Follow-up.
|
N/A | |
Recruiting |
NCT05065073 -
Iso-Osmolar vs. Low-Osmolar Contrast Agents for Optical Coherence Tomography
|
Phase 4 | |
Completed |
NCT05096442 -
Compare the Safety and Efficacy of Genoss® DCB and SeQuent® Please NEO in Korean Patients With Coronary De Novo Lesions
|
N/A |